Comments
Loading...

Biolase

BIOLOTCQB
Logo brought to you by Benzinga Data
$0.055700
-0.0022-3.80%
At Close: -
$0.054250
-0.0014-2.60%
After Hours: Aug 26, 8:39 AM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$12.00
Lowest Price Target1
$0.40
Consensus Price Target1
$3.16

Biolase (OTC:BIOL) Stock, Analyst Ratings, Price Targets, Forecasts

Biolase Inc has a consensus price target of $3.16 based on the ratings of 5 analysts. The high is $12 issued by Lake Street on May 20, 2022. The low is $0.4 issued by Benchmark on August 12, 2024. The 3 most-recent analyst ratings were released by Ascendiant Capital, Benchmark, and Benchmark on September 3, 2024, August 12, 2024, and May 14, 2024, respectively. With an average price target of $0.93 between Ascendiant Capital, Benchmark, and Benchmark, there's an implied 1620.43% upside for Biolase Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
0
0
0
0
Apr
0
0
0
0
May
0
0
0
0
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.2
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Ascendiant Capital
Benchmark
Lake Street
Maxim Group
Lake Street

1calculated from analyst ratings

Analyst Ratings for Biolase

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Biolase (BIOL) stock?

A

The latest price target for Biolase (OTCQB:BIOL) was reported by Ascendiant Capital on September 3, 2024. The analyst firm set a price target for $2.00 expecting BIOL to rise to within 12 months (a possible 3586.64% upside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Biolase (BIOL)?

A

The latest analyst rating for Biolase (OTCQB:BIOL) was provided by Ascendiant Capital, and Biolase maintained their buy rating.

Q

When was the last upgrade for Biolase (BIOL)?

A

There is no last upgrade for Biolase

Q

When was the last downgrade for Biolase (BIOL)?

A

There is no last downgrade for Biolase.

Q

When is the next analyst rating going to be posted or updated for Biolase (BIOL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biolase, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biolase was filed on September 3, 2024 so you should expect the next rating to be made available sometime around September 3, 2025.

Q

Is the Analyst Rating Biolase (BIOL) correct?

A

While ratings are subjective and will change, the latest Biolase (BIOL) rating was a maintained with a price target of $3.50 to $2.00. The current price Biolase (BIOL) is trading at is $0.05, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.